Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
64
ABOS Quote, Financials, Valuation and Earnings
Last price:
$2.17
Seasonality move
:
-5.23%
Day range:
$2.12 - $2.18
52-week range:
$0.86 - $2.46
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.41x
Volume:
202.4K
Avg. volume:
169.7K
1-year change:
20.67%
Market cap:
$131.4M
Revenue:
--
EPS (TTM):
-$2.21
Earnings Data
Next earnings date for ABOS
Mar 24
2026
Most recent earnings per share
-$0.44
Beat by $0.24
(Nov 12/2025)
Consensus Estimate
-$0.68
(Nov 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ABOS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/24/2026 | Q4 | -- | -- | -- | -$0.56 | -- |
| 11/12/2025 | Q3 | -- | -- | -$0.44 | -$0.68 | $0.24 |
| 08/12/2025 | Q2 | -- | -- | -$0.68 | -$0.52 | -$0.16 |
| 05/15/2025 | Q1 | -- | -- | -$0.48 | -$0.55 | $0.07 |
| 03/27/2025 | Q4 | -- | -- | -$0.62 | -$0.37 | -$0.25 |
| 11/12/2024 | Q3 | -- | -- | -$0.50 | -$0.30 | -$0.20 |
| 08/13/2024 | Q2 | -- | -- | -$0.34 | -$0.25 | -$0.09 |
| 05/14/2024 | Q1 | -- | -- | -$0.25 | -$0.23 | -$0.01 |
| 03/26/2024 | Q4 | -- | -- | -$0.28 | -$0.25 | -$0.03 |
| 11/13/2023 | Q3 | -- | -- | -$0.24 | -$0.26 | $0.02 |
| 08/08/2023 | Q2 | -- | -- | -$0.28 | -- | -- |
| 05/09/2023 | Q1 | -- | -- | -$0.28 | -- | -- |
| 03/27/2023 | Q4 | -- | -- | -$0.31 | -- | -- |
| 11/14/2022 | Q3 | -- | -- | -$0.26 | -- | -- |
| 08/15/2022 | Q2 | -- | -- | -$0.25 | -- | -- |
| 05/16/2022 | Q1 | -- | -- | -$0.23 | -- | -- |
| 03/28/2022 | Q4 | -- | -- | -$0.21 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | -$0.10 | -- | -- |
| 08/16/2021 | Q2 | -- | -- | -$1.52 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.67 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.03 | -- | -- |
| 09/30/2020 | Q3 | -- | $730K | -$0.06 | -- | -- |
| 06/30/2020 | Q2 | -- | $151K | -$0.05 | -- | -- |
| 03/31/2020 | Q1 | -- | $226K | -$0.05 | -- | -- |
Acumen Pharmaceuticals, Inc. Earnings Questions
-
How Much did Acumen Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
Acumen Pharmaceuticals, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Acumen Pharmaceuticals, Inc. Beat Earnings Last Quarter?
Acumen Pharmaceuticals, Inc. announced earnings per share of -$0.44 which represents a beat of analyst forecast a -$0.68 per share.
-
Is Acumen Pharmaceuticals, Inc. Profitable?
Acumen Pharmaceuticals, Inc. reported -$47K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Acumen Pharmaceuticals, Inc. EPS Next Year?
Acumen Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$1.71 per share to -$1.32 per share next year representing a decrease of -34%.
-
When is Acumen Pharmaceuticals, Inc.'s Earnings Date?
Acumen Pharmaceuticals, Inc.'s next earnings date is March 24, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
